NVP Associates, LLC
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 7, 2026), NVP Associates, LLC reported 7 stock positions worth $328.2 million. Its top holding was MBX Biosciences (MBX) at 35.9% of the portfolio, followed by Avalyn Pharma (AVLN, 22.8%) and Omada Health (OMDA, 16.9%). Compared with Q1 2026, it opened 3 new positions and sold out of 1. The biggest buy was a new position in Avalyn Pharma (AVLN) and the biggest sale an exit from Billiontoone Class A (BLLN).
- Most Recent 13F
- Q2 2026
- Location
- MENLO PARK, CA
- CIK
- 0001545692
- Portfolio Value
- $328.2M (Q2 2026)
- SEC Filing
- 0001545692-26-000009 ↗ filed Aug 7, 2026
Holdings Value
Holdings 7 stocks · $328.2M
| MBX MBX Biosciences Inc. | 35.93% | 2,136,335 | $117.9M | No change |
| AVLN Avalyn Pharma Inc. | 22.75% | 2,268,404 | $74.7M | New |
| OMDA Omada Health Inc. | 16.93% | 2,531,000 | $55.6M | No change |
| ZBIO Zenas Biopharma Inc. | 14.22% | 1,838,482 | $46.7M | No change |
| SNOW Snowflake Inc. | 8.90% | 114,786 | $29.2M | New |
| GROV Grove Collaborative Holdings | 1.23% | 3,225,097 | $4.0M | No change |
| ONDS Ondas Inc. | 0.04% | 15,602 | $129K | New |
Portfolio Sells Q1 2026 → Q2 2026
| BLLN Billiontoone Inc. Class A | Sold out | 0.00% | −23.00 |
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 7 | $328.2M | MBX, AVLN, OMDA, ZBIO, SNOW |
| Q1 2026 | 5 | $176.2M | MBX, BLLN, ZBIO, OMDA, GROV |
| Q4 2025 | 6 | $255.2M | MBX, ZBIO, BLLN, OMDA, TALK |
| Q3 2025 | 5 | $166.1M | OMDA, ZBIO, MBX, TALK, GROV |
| Q2 2025 | 7 | $184.2M | DAVE, OMDA, TALK, MBX, ZBIO |
| Q1 2025 | 6 | $112.2M | DAVE, TALK, MBX, ZBIO, GROV |
| Q4 2024 | 7 | $186.9M | DAVE, TALK, MBX, UDMY, ZBIO |
| Q3 2024 | 8 | $176.1M | MBX, ZBIO, TALK, DAVE, UDMY |
| Q2 2024 | 6 | $91.3M | TALK, UDMY, DAVE, OPEN, GROV |
| Q1 2024 | 6 | $125.9M | TALK, UDMY, DAVE, OPEN, GROV |